logo
Select company
Select metric
$ -48.14MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
18
Sector
16
Industry
10
History
56
$ 1.31Close
$ 0.83 - $ 5.59 52-Week Range
Ticker Information

Ticker

CGC

Company Name

CANOPY GROWTH CORP

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

CANOPY GROWTH CORP - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CGC - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -48.14M
3/31/2025$ -40.35M
12/31/2024$ 13.31M
9/30/2024$ -10.55M
6/30/2024$ -245.4M
3/31/2024$ -372.58M
12/31/2023$ -339.84M
9/30/2023$ -367.7M
6/30/2023$ -178.96M
3/31/2023$ -74.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CANOPY GROWTH CORP's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -327.62M.
  • Over the past 5 years, CANOPY GROWTH CORP's average CF - Chg. Cash has been $ -163.11M.
  • The median CF - Chg. Cash for CANOPY GROWTH CORP during this period was $ -144.49M
  • CANOPY GROWTH CORP reached its highest CF - Chg. Cash over the past 5 years at $ 162.52M.
  • The lowest CF - Chg. Cash recorded by CANOPY GROWTH CORP in the same timeframe $ -571.09M

CANOPY GROWTH CORP's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
LFCR : LIFECORE BIOMEDICAL INC $ -197KOGI : ORGANIGRAM GLOBAL INC $ -14.66MACB : AURORA CANNABIS INC $ 1.47MESPR : ESPERION THERAPEUTICS INC $ -103.24MSIGA : SIGA TECHNOLOGIES INC $ 75.51MVNDA : VANDA PHARMACEUTICALS INC $ -21.97MGLUE : MONTE ROSA THERAPEUTICS INC $ -39.33MCERS : CERUS CORP $ 3.02MTMCI : TREACE MEDICAL CONCEPTS INC $ -10.13MRXST : RXSIGHT INC $ 15.95M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

CGC - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -571.09M

Minimum

Dec 31, 2020

$ 162.52M

Maximum

Jun 30, 2022

$ -163.11M

Average

$ -144.49M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M